Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (opens new window)

Barillari G, Pasca S, Barillari A, De Angelis V.

Allikas‎: Blood Transfus 2012;10(1):87-94.

Indekseeritud‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (opens new window)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (opens new window)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Allikas‎: Chest 2012;141(2 Suppl):e326S-50S.

Indekseeritud‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (opens new window)

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. (opens new window)

Flordal PA.

Allikas‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

Indekseeritud‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 (opens new window)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opens new window)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Allikas‎: Lancet 2015;385(9982):2077-87.

Indekseeritud‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (opens new window)

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. (opens new window)

Goodnough LT, Shander A.

Allikas‎: Blood 2011;117(23):6091-9.

Indekseeritud‎: PubMed 21411756

DOI‎: 10.1182/blood-2010-11-316075

https://www.ncbi.nlm.nih.gov/pubmed/21411756 (opens new window)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (opens new window)

Hanke AA, Joch C, Görlinger K.

Allikas‎: Br J Anaesth 2013;110(5):764-72.

Indekseeritud‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (opens new window)

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature. (opens new window)

Jaben EA, Mulay SB, Stubbs JR.

Allikas‎: J Intensive Care Med 2015;30(1):3-7.

Indekseeritud‎: PubMed 25492811

DOI‎: 10.1177/0885066613487298

https://www.ncbi.nlm.nih.gov/pubmed/25492811 (opens new window)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (opens new window)

Levi M, Eerenberg E, Kamphuisen PW.

Allikas‎: J Thromb Haemost 2011;9(9):1705-12.

Indekseeritud‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (opens new window)

Emergency reversal of warfarin anticoagulation. (opens new window)

Lin Y, Callum J.

Allikas‎: CMAJ 2010;182(18):2004.

Indekseeritud‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (opens new window)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (opens new window)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Allikas‎: Thromb Haemost 2012;108(2):217-24.

Indekseeritud‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (opens new window)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (opens new window)

Mo Y, Yam FK.

Allikas‎: Pharmacotherapy 2015;35(2):198-207.

Indekseeritud‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (opens new window)

Idarucizumab for dabigatran reversal - full cohort analysis. (opens new window)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Allikas‎: N Engl J Med 2017;377(5):431-41.

Indekseeritud‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (opens new window)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (opens new window)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Allikas‎: Anesth Analg 2011;113(4):703-10.

Indekseeritud‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (opens new window)

Oral anticoagulation in surgical procedures: risks and recommendations. (opens new window)

Torn M, Rosendaal FR.

Allikas‎: Br J Haematol 2003;123(4):676-82.

Indekseeritud‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (opens new window)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (opens new window)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Allikas‎: Blood 2012;119(9):2172-4.

Indekseeritud‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (opens new window)